* GoodRx Holdings Inc reported quarterly adjusted earnings of 8 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 6 cents. The mean expectation of seventeen analysts for the quarter was for earnings of 9 cents per share. Wall Street expected results to range from 7 cents to 11 cents per share.
* Revenue rose 8.5% to $195.25 million from a year ago; analysts expected $195.65 million.
* GoodRx Holdings Inc's reported EPS for the quarter was 1 cent.
* The company reported quarterly net income of $3.97 million.
* GoodRx Holdings Inc shares had fallen by 12.0% this quarter and lost 8.8% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by about 4.3% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy," 7 "hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the online services peer group is also "buy"
Wall Street's median 12-month price target for GoodRx Holdings Inc is $9.25 This summary was machine generated from LSEG data November 7 at 02:42 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 0.09 0.08 Missed
Jun. 30 2024 0.08
Mar. 31 2024 0.08 0.08 Met
Dec. 31 2023 0.07 0.08 Beat
Comments